Ketogenic Diet: A Nutritional Therapeutic Tool for Lipedema?
Diet
Fat
Inflammation
Lipedema
Nutrition
Obesity
Very low-calorie ketogenic diet
Journal
Current obesity reports
ISSN: 2162-4968
Titre abrégé: Curr Obes Rep
Pays: United States
ID NLM: 101578283
Informations de publication
Date de publication:
04 Nov 2023
04 Nov 2023
Historique:
accepted:
19
09
2023
medline:
4
11
2023
pubmed:
4
11
2023
entrez:
4
11
2023
Statut:
aheadofprint
Résumé
This review aims to provide an overview of the current evidence on the efficacy, also considering the anti-inflammatory properties and safety of very low-calorie ketogenic diet (VLCKD) as a potential treatment for lipedema, particularly in the context of obesity. Lipedema is a chronic disease characterized by abnormal and painful fat buildup on the legs and/or arms. It is often misdiagnosed as obesity or lymphedema. However, although lipedema and obesity can coexist, unlike obesity, lipedema usually affects the legs and thighs without affecting the feet or hands, and the abnormal deposition of adipose tissue in lipedema is painful. The current lifestyle interventions are often unsuccessful in the management of lipedema. There is no consensus on the most effective nutritional approach for managing lipedema. Recent studies have suggested that VLCKD may be an effective treatment for lipedema, demonstrating that it is also superior to other nutritional approaches such as Mediterranean diet or intermittent fasting. Lipedema is a chronic and debilitating disease characterized by abnormal and painful accumulation of adipose tissue in the legs. VLCKD has been shown to be an effective treatment for lipedema, especially in the context of obesity, due to its anti-inflammatory properties. However, further research is needed to determine the long-term safety and efficacy of VLCKD as a treatment for lipedema.
Identifiants
pubmed: 37924422
doi: 10.1007/s13679-023-00536-x
pii: 10.1007/s13679-023-00536-x
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Buso G, Depairon M, Tomson D, Raffoul W, Vettor R, Mazzolai L. Lipedema: a call to action! Obesity (Silver Spring). 2019;27(10):1567–76.
pubmed: 31544340
doi: 10.1002/oby.22597
Aksoy H, Karadag AS, Wollina U. Cause and management of lipedema-associated pain. Dermatol Ther. 2021;34(1):e14364.
Vyas A, Adnan G. Lipedema. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Ghufran Adnan declares no relevant financial relationships with ineligible companies. 2023.
Katzer K, Hill JL, McIver KB, Foster MT. Lipedema and the potential role of estrogen in excessive adipose tissue accumulation. Int J Mol Sci. 2021;22(21): 11720-11732. https://doi.org/10.3390/ijms222111720 .
Chen SG, Hsu SD, Chen TM, Wang HJ. Painful fat syndrome in a male patient. Br J Plast Surg. 2004;57(3):282–6.
pubmed: 15006533
doi: 10.1016/j.bjps.2003.12.020
Giunta RE. Focus “liposuction in lipedema.” Handchir Mikrochir Plast Chir. 2018;50(6):379.
pubmed: 30620974
Pereira de Godoy LM, Guerreiro Godoy MF, Pereira de Godoy JM. Lipedema in male progressing to subclinical and clinical systemic lymphedema. J Med Cases. 2022;13(6):249–52.
Child AH, Gordon KD, Sharpe P, Brice G, Ostergaard P, Jeffery S, et al. Lipedema: an inherited condition. Am J Med Genet A. 2010;152A(4):970–6.
pubmed: 20358611
doi: 10.1002/ajmg.a.33313
Paolacci S, Precone V, Acquaviva F, Chiurazzi P, Fulcheri E, Pinelli M, et al. Genetics of lipedema: new perspectives on genetic research and molecular diagnoses. Eur Rev Med Pharmacol Sci. 2019;23(13):5581–94.
pubmed: 31298310
Szel E, Kemeny L, Groma G, Szolnoky G. Pathophysiological dilemmas of lipedema. Med Hypotheses. 2014;83(5):599–606.
pubmed: 25200646
doi: 10.1016/j.mehy.2014.08.011
Organization WH. Obesity and overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight .
Shavit E, Wollina U, Alavi A. Lipoedema is not lymphoedema: a review of current literature. Int Wound J. 2018;15(6):921–8.
pubmed: 29956468
pmcid: 7949771
doi: 10.1111/iwj.12949
Poojari A, Dev K, Rabiee A. Lipedema: insights into morphology, pathophysiology, and challenges. Biomedicines. 2022;10(12):3081–3114. https://doi.org/10.3390/biomedicines10123081 .
Herbst KL, Kahn LA, Iker E, Ehrlich C, Wright T, McHutchison L, et al. Standard of care for lipedema in the United States. Phlebology. 2021;36(10):779–96.
pubmed: 34049453
pmcid: 8652358
doi: 10.1177/02683555211015887
Muscogiuri G, Verde L, Sulu C, Katsiki N, Hassapidou M, Frias-Toral E, et al. Mediterranean diet and obesity-related disorders: what is the evidence? Curr Obes Rep. 2022;11(4):287–304.
pubmed: 36178601
pmcid: 9729142
doi: 10.1007/s13679-022-00481-1
Welton S, Minty R, O’Driscoll T, Willms H, Poirier D, Madden S, et al. Intermittent fasting and weight loss: systematic review. Can Fam Physician. 2020;66(2):117–25.
pubmed: 32060194
pmcid: 7021351
Muscogiuri G, El Ghoch M, Colao A, Hassapidou M, Yumuk V, Busetto L, et al. European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis. Obes Facts. 2021;14(2):222–45.
pubmed: 33882506
pmcid: 8138199
doi: 10.1159/000515381
Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, et al. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids. 2008;43(1):65–77.
pubmed: 18046594
doi: 10.1007/s11745-007-3132-7
Sørlie V, De Soysa AK, Hyldmo AA, Retterstol K, Martins C, Nymo S. Effect of a ketogenic diet on pain and quality of life in patients with lipedema: the LIPODIET pilot study. Obes Sci Pract. 2022;8(4):483–93.
Cannataro R, Michelini S, Ricolfi L, Caroleo MC, Gallelli L, De Sarro G, Onorato A, Cione E. Management of lipedema with ketogenic diet: 22-month follow-up. Life (Basel). 2021;11(12)12):1402–1412. https://doi.org/10.3390/life11121402 .
Wollina U. Lipedema-an update. Dermatol Ther. 2019;32(2):e12805.
Schwahn-Schreiber MMC. Prävalenz des Lipödems bei berufs-tätigen Frauen in Deutschland (Lipödem-3-Studie). 2011.
Buck DW 2nd, Herbst KL. Lipedema: a relatively common disease with extremely common misconceptions. Plast Reconstr Surg Glob Open. 2016;4(9):e1043.
Reich-Schupke S, Schmeller W, Brauer WJ, Cornely ME, Faerber G, Ludwig M, et al. S1 guidelines: lipedema. J Dtsch Dermatol Ges. 2017;15(7):758–67.
pubmed: 28677176
doi: 10.1111/ddg.13036
Kruppa P, Georgiou I, Biermann N, Prantl L, Klein-Weigel P, Ghods M. Lipedema-pathogenesis, diagnosis, and treatment options. Dtsch Arztebl Int. 2020;117(22–23):396–403.
pubmed: 32762835
pmcid: 7465366
Torre YS, Wadeea R, Rosas V, Herbst KL. Lipedema: friend and foe. Horm Mol Biol Clin Investig. 2018;33(1).
Halk AB, Damstra RJ. First Dutch guidelines on lipedema using the international classification of functioning, disability and health. Phlebology. 2017;32(3):152–9.
pubmed: 27075680
doi: 10.1177/0268355516639421
Hardy D, Williams A. Best practice guidelines for the management of lipoedema. Br J Community Nurs. 2017;22(Sup10):S44–S48. https://doi.org/10.12968/bjcn.2017.22.Sup10.S44 .
Chakraborty A, Crescenzi R, Usman TA, Reyna AJ, Garza ME, Al-Ghadban S, Herbst KL, Donahue PMC, Rutkowski JM. Indications of peripheral pain, dermal hypersensitivity, and neurogenic inflammation in patients with lipedema. Int J Mol Sci. 2022;23(18):10313–10328. https://doi.org/10.3390/ijms231810313 .
Ratchford EV, Evans NS. Approach to lower extremity edema. Curr Treat Options Cardiovasc Med. 2017;19(3):16.
pubmed: 28290004
doi: 10.1007/s11936-017-0518-6
Hirschmann JV, Raugi GJ. Lower limb cellulitis and its mimics: part I. Lower limb cellulitis. J Am Acad Dermatol. 2012;67(2):163 e1–12; quiz 75–6.
Hirsch T, Schleinitz J, Marshall M, Faerber G. Ist die differenzial diagnostik des lipödems mittels hochauflösender Sonografie möglich? Is the differential diagnosis of lipoedema by means of high-resolution ultrasonography possible? Phlebologie. 2018;47:182–7.
Birkballe S, Jensen MR, Noerregaard S, Gottrup F, Karlsmark T. Can tissue dielectric constant measurement aid in differentiating lymphoedema from lipoedema in women with swollen legs? Br J Dermatol. 2014;170(1):96–102.
pubmed: 24033279
doi: 10.1111/bjd.12589
Dietzel R, Reisshauer A, Jahr S, Calafiore D, Armbrecht G. Body composition in lipoedema of the legs using dual-energy X-ray absorptiometry: a case-control study. Br J Dermatol. 2015;173(2):594–6.
pubmed: 25641018
doi: 10.1111/bjd.13697
Romeijn JRM, de Rooij MJM, Janssen L, Martens H. Exploration of patient characteristics and quality of life in patients with lipoedema using a survey. Dermatol Ther (Heidelb). 2018;8(2):303–11.
pubmed: 29748843
doi: 10.1007/s13555-018-0241-6
Erbacher TBG. Lipödem – Mythen und Fakten Teil 2. Phlebologie. 2018;47:120–6.
doi: 10.12687/phleb2418-3-2018
Forner-Cordero I, Szolnoky G, Forner-Cordero A, Kemeny L. Lipedema: an overview of its clinical manifestations, diagnosis and treatment of the disproportional fatty deposition syndrome - systematic review. Clin Obes. 2012;2(3–4):86–95.
pubmed: 25586162
doi: 10.1111/j.1758-8111.2012.00045.x
Herbst KL. Rare adipose disorders (RADs) masquerading as obesity. Acta Pharmacol Sin. 2012;33(2):155–72.
pubmed: 22301856
pmcid: 4010336
doi: 10.1038/aps.2011.153
Dudek JE, Bialaszek W, Ostaszewski P, Smidt T. Depression and appearance-related distress in functioning with lipedema. Psychol Health Med. 2018;23(7):846–53.
pubmed: 29614880
doi: 10.1080/13548506.2018.1459750
Cornier MA, Despres JP, Davis N, Grossniklaus DA, Klein S, Lamarche B, et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation. 2011;124(18):1996–2019.
pubmed: 21947291
doi: 10.1161/CIR.0b013e318233bc6a
Jeziorek M, Szuba A, Kujawa K, Regulska-Ilow B. The effect of a low-carbohydrate, high-fat diet versus moderate-carbohydrate and fat diet on body composition in patients with lipedema. Diabetes Metab Syndr Obes. 2022;15:2545–61.
pubmed: 36035515
pmcid: 9415463
doi: 10.2147/DMSO.S377720
Czerwinska M, Teodorczyk J, Hansdorfer-Korzon R. A scoping review of available tools in measurement of the effectiveness of conservative treatment in lipoedema. Int J Environ Res Public Health. 2022;19(12):7124–7135. https://doi.org/10.3390/ijerph19127124 .
Herbst KL, Ussery C, Eekema A. Pilot study: whole body manual subcutaneous adipose tissue (SAT) therapy improved pain and SAT structure in women with lipedema. Horm Mol Biol Clin Investig. 2017;33(2).
Minetto MA, Pietrobelli A, Busso C, Bennett JP, Ferraris A, Shepherd JA, et al. Digital anthropometry for body circumference measurements: European phenotypic variations throughout the decades. J Pers Med. 2022;12(6).
Marra M, Sammarco R, De Lorenzo A, Iellamo F, Siervo M, Pietrobelli A, et al. Assessment of body composition in health and disease using bioelectrical impedance analysis (BIA) and dual energy X-ray absorptiometry (DXA): a critical overview. Contrast Media Mol Imaging. 2019;2019:3548284.
pubmed: 31275083
pmcid: 6560329
doi: 10.1155/2019/3548284
Reljic D, Zarafat D, Jensen B, Herrmann HJ, Neurath MF, Konturek PC, et al. Phase angle and vector analysis from multifrequency segmental bioelectrical impedance analysis: new reference data for older adults. J Physiol Pharmacol. 2020;71(4).
Di Renzo L, Cinelli G, Romano L, Zomparelli S, Lou De Santis G, Nocerino P, et al. Potential effects of a modified Mediterranean diet on body composition in lipoedema. Nutrients. 2021;13(2).
Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gomez J, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004;23(6):1430–53.
pubmed: 15556267
doi: 10.1016/j.clnu.2004.09.012
Norman K, Stobaus N, Pirlich M, Bosy-Westphal A. Bioelectrical phase angle and impedance vector analysis–clinical relevance and applicability of impedance parameters. Clin Nutr. 2012;31(6):854–61.
pubmed: 22698802
doi: 10.1016/j.clnu.2012.05.008
Barrea L, Muscogiuri G, Pugliese G, Laudisio D, de Alteriis G, Graziadio C, et al. Phase angle as an easy diagnostic tool of meta-inflammation for the nutritionist. Nutrients. 2021;13(5).
Barrea L, Pugliese G, de Alteriis G, Colao A, Savastano S, Muscogiuri G. Phase angle: could be an easy tool to detect low-grade systemic inflammation in adults affected by Prader-Willi syndrome? Nutrients. 2020;12(7).
Barrea L, Muscogiuri G, Aprano S, Vetrani C, de Alteriis G, Varcamonti L, et al. Phase angle as an easy diagnostic tool for the nutritionist in the evaluation of inflammatory changes during the active stage of a very low-calorie ketogenic diet. Int J Obes (Lond). 2022;46(9):1591–7.
pubmed: 35614205
doi: 10.1038/s41366-022-01152-w
Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol. 2011;11(11):738–49.
pubmed: 21984069
pmcid: 3383854
doi: 10.1038/nri3071
Crino A, Fintini D, Bocchini S, Grugni G. Obesity management in Prader-Willi syndrome: current perspectives. Diabetes Metab Syndr Obes. 2018;11:579–93.
pubmed: 30323638
pmcid: 6175547
doi: 10.2147/DMSO.S141352
Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2019;10:1607.
pubmed: 32063863
doi: 10.3389/fphys.2019.01607
Ward LC. Segmental bioelectrical impedance analysis: an update. Curr Opin Clin Nutr Metab Care. 2012;15(5):424–9.
pubmed: 22814626
doi: 10.1097/MCO.0b013e328356b944
Cornish BH, Jacobs A, Thomas BJ, Ward LC. Optimizing electrode sites for segmental bioimpedance measurements. Physiol Meas. 1999;20(3):241–50.
pubmed: 10475578
doi: 10.1088/0967-3334/20/3/302
Yamada Y, Masuo Y, Yokoyama K, Hashii Y, Ando S, Okayama Y, et al. Proximal electrode placement improves the estimation of body composition in obese and lean elderly during segmental bioelectrical impedance analysis. Eur J Appl Physiol. 2009;107(2):135–44.
pubmed: 19533166
doi: 10.1007/s00421-009-1106-6
Lontok E. Lipedema-Giving-Smarter-Guide. 2021.
Langendoen SI, Habbema L, Nijsten TE, Neumann HA. Lipoedema: from clinical presentation to therapy. A review of the literature. Br J Dermatol. 2009;161(5):980–6.
Szolnoky G, Nagy N, Kovacs RK, Dosa-Racz E, Szabo A, Barsony K, et al. Complex decongestive physiotherapy decreases capillary fragility in lipedema. Lymphology. 2008;41(4):161–6.
pubmed: 19306662
Szolnoky G, Varga E, Varga M, Tuczai M, Dosa-Racz E, Kemeny L. Lymphedema treatment decreases pain intensity in lipedema. Lymphology. 2011;44(4):178–82.
pubmed: 22458119
Wollina U, Heinig B, Schonlebe J, Nowak A. Debulking surgery for elephantiasis nostras with large ectatic podoplanin-negative lymphatic vessels in patients with lipo-lymphedema. Eplasty. 2014;14:e11.
Peprah K, MacDougall D. Liposuction for the treatment of lipedema: a review of clinical effectiveness and guidelines. CADTH rapid response reports. Ottawa (ON). 2019.
Baumgartner A, Hueppe M, Schmeller W. Long-term benefit of liposuction in patients with lipoedema: a follow-up study after an average of 4 and 8 years. Br J Dermatol. 2016;174(5):1061–1067. https://doi.org/10.1111/bjd.14289 .
Dadras M, Mallinger PJ, Corterier CC, Theodosiadi S, Ghods M. Liposuction in the treatment of lipedema: a longitudinal study. Arch Plast Surg. 2017;44(4):324–31.
pubmed: 28728329
pmcid: 5533060
doi: 10.5999/aps.2017.44.4.324
Rapprich S, Dingler A, Podda M. Liposuction is an effective treatment for lipedema-results of a study with 25 patients. J Dtsch Dermatol Ges. 2011;9(1):33–40.
pubmed: 21166777
Falck J, Rolander B, Nygardh A, Jonasson LL, Martensson J. Women with lipoedema: a national survey on their health, health-related quality of life, and sense of coherence. BMC Womens Health. 2022;22(1):457.
pubmed: 36401222
pmcid: 9673372
doi: 10.1186/s12905-022-02022-3
Bertsch T, Erbacher G, Elwell R. Lipoedema: a paradigm shift and consensus. J Wound Care. 2020;29(Sup11b):1–51.
pubmed: 33170068
doi: 10.12968/jowc.2020.29.Sup11b.1
Dudek JE, Bialaszek W, Ostaszewski P. Quality of life in women with lipoedema: a contextual behavioral approach. Qual Life Res. 2016;25(2):401–8.
pubmed: 26216585
doi: 10.1007/s11136-015-1080-x
Organization WH. International statistical classification of diseases and related health problems (11th Revision). Available from: http://id.who.int/icd/entity/1172950828
Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45.
pubmed: 21219177
doi: 10.1146/annurev-immunol-031210-101322
Xu H. Obesity and metabolic inflammation. Drug Discov Today Dis Mech. 2013;10(1–2).
Wallach D, Kang TB, Kovalenko A. Concepts of tissue injury and cell death in inflammation: a historical perspective. Nat Rev Immunol. 2014;14(1):51–9.
pubmed: 24336099
doi: 10.1038/nri3561
Jeffery E, Wing A, Holtrup B, Sebo Z, Kaplan JL, Saavedra-Pena R, et al. The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity. Cell Metab. 2016;24(1):142–50.
pubmed: 27320063
pmcid: 4945385
doi: 10.1016/j.cmet.2016.05.012
Ioannidou A, Fisher RM, Hagberg CE. The multifaceted roles of the adipose tissue vasculature. Obes Rev. 2022;23(4):e13403. https://doi.org/10.1111/obr.13403 .
Hammarstedt A, Gogg S, Hedjazifar S, Nerstedt A, Smith U. Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity. Physiol Rev. 2018;98(4):1911–41.
pubmed: 30067159
doi: 10.1152/physrev.00034.2017
Felmerer G, Stylianaki A, Hagerling R, Wang A, Strobel P, Hollmen M, et al. Adipose tissue hypertrophy, an aberrant biochemical profile and distinct gene expression in lipedema. J Surg Res. 2020;253:294–303.
pubmed: 32407981
doi: 10.1016/j.jss.2020.03.055
Ishaq M, Bandara N, Morgan S, Nowell C, Mehdi AM, Lyu R, et al. Key signaling networks are dysregulated in patients with the adipose tissue disorder, lipedema. Int J Obes (Lond). 2022;46(3):502–14.
pubmed: 34764426
doi: 10.1038/s41366-021-01002-1
Ibarra M, Eekema A, Ussery C, Neuhardt D, Garby K, Herbst KL. Subcutaneous adipose tissue therapy reduces fat by dual X-ray absorptiometry scan and improves tissue structure by ultrasound in women with lipoedema and Dercum disease. Clin Obes. 2018;8(6):398–406.
pubmed: 30248251
doi: 10.1111/cob.12281
Suga H, Araki J, Aoi N, Kato H, Higashino T, Yoshimura K. Adipose tissue remodeling in lipedema: adipocyte death and concurrent regeneration. J Cutan Pathol. 2009;36(12):1293–8. https://doi.org/10.1111/j.1600-0560.2009.01256.x .
Shah JP, Danoff JV, Desai MJ, Parikh S, Nakamura LY, Phillips TM, et al. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil. 2008;89(1):16–23.
pubmed: 18164325
doi: 10.1016/j.apmr.2007.10.018
Olszewski WL, Ambujam PJ, Zaleska M, Cakala M. Where do lymph and tissue fluid accumulate in lymphedema of the lower limbs caused by obliteration of lymphatic collectors? Lymphology. 2009;42(3):105–11.
pubmed: 19927899
Ma W, Gil HJ, Escobedo N, Benito-Martin A, Ximenez-Embun P, Munoz J, et al. Platelet factor 4 is a biomarker for lymphatic-promoted disorders. JCI Insight. 2020;5(13).
Crescenzi R, Marton A, Donahue PMC, Mahany HB, Lants SK, Wang P, et al. Tissue sodium content is elevated in the skin and subcutaneous adipose tissue in women with lipedema. Obesity (Silver Spring). 2018;26(2):310–7.
pubmed: 29280322
doi: 10.1002/oby.22090
Al-Ghadban S, Cromer W, Allen M, Ussery C, Badowski M, Harris D, Herbst KL. Dilated blood and lymphatic microvessels, angiogenesis, increased macrophages, and adipocyte hypertrophy in lipedema thigh skin and fat tissue. J Obes. 2019;2019:8747461. https://doi.org/10.1155/2019/8747461 .
Priglinger E, Wurzer C, Steffenhagen C, Maier J, Hofer V, Peterbauer A, et al. The adipose tissue-derived stromal vascular fraction cells from lipedema patients: are they different? Cytotherapy. 2017;19(7):849–60.
pubmed: 28454682
doi: 10.1016/j.jcyt.2017.03.073
Pereira de Godoy LM, Pereira de Godoy HJ, Pereira de Godoy Capeletto P, Guerreiro Godoy MF, Pereira de Godoy JM. Lipedema and the evolution to lymphedema with the progression of obesity. Cureus. 2020;12(12):e11854. https://doi.org/10.7759/cureus.11854 .
Schmitt R, Lucas D, Buhmann S, Lanz U, Schindler G. Morphometry using computerized tomography of the wrist in idiopathic carpal tunnel syndrome. Comparison of pre- and postoperative findings. Handchir Mikrochir Plast Chir. 1988;20(1):41–6.
Keith L, Seo CA, Rowsemitt C, Pfeffer M, Wahi M, Staggs M, Dudek J, Gower B, Carmody M. Ketogenic diet as a potential intervention for lipedema. Med Hypotheses. 2021;146:110435. https://doi.org/10.1016/j.mehy.2020.110435 .
Trimboli P, Castellana M, Bellido D, Casanueva FF. Confusion in the nomenclature of ketogenic diets blurs evidence. Rev Endocr Metab Disord. 2020;21(1):1–3.
pubmed: 32080796
doi: 10.1007/s11154-020-09546-9
Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, et al. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). J Endocrinol Invest. 2019;42(11):1365–86.
pubmed: 31111407
doi: 10.1007/s40618-019-01061-2
Goday A, Bellido D, Sajoux I, Crujeiras AB, Burguera B, Garcia-Luna PP, Oleaga A, Moreno B, Casanueva FF. Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutr Diabetes. 2016;6(9):e230. https://doi.org/10.1038/nutd.2016.36 .
Romano L, Marchetti M, Gualtieri P, Di Renzo L, Belcastro M, De Santis GL, Perrone MA, De Lorenzo A. Effects of a personalized VLCKD on body composition and resting energy expenditure in the reversal of diabetes to prevent complications. Nutrients. 2019;11(7):1526–39. https://doi.org/10.3390/nu11071526 .
Castellana M, Conte E, Cignarelli A, Perrini S, Giustina A, Giovanella L, et al. Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: a systematic review and meta-analysis. Rev Endocr Metab Disord. 2020;21(1):5–16.
pubmed: 31705259
doi: 10.1007/s11154-019-09514-y
EFSA. EFSA - European Food Safety Authority 2015. Available from: https://www.efsa.europa.eu/en .
O’Neill B, Raggi P. The ketogenic diet: pros and cons. Atherosclerosis. 2020;292:119–26.
pubmed: 31805451
doi: 10.1016/j.atherosclerosis.2019.11.021
Mancini JG, Filion KB, Atallah R, Eisenberg MJ. Systematic review of the Mediterranean diet for long-term weight loss. Am J Med. 2016;129(4):407–15e4.
Verde L, Dalamaga M, Capo X, Annunziata G, Hassapidou M, Docimo A, et al. The antioxidant potential of the Mediterranean diet as a predictor of weight loss after a very low-calorie ketogenic diet (VLCKD) in women with overweight and obesity. Antioxidants (Basel). 2022;12(1).